Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by β-amyloid peptide 25-35 in young mice

Biogerontology

Volumn 7, Issue 4, 2006, Pages 239-247

  Ahn, J ^a   Um, M ^a   Choi, W ^a   Kim, S ^a   Ha, T ^a  

^a Korea Food Research Institute   (South Korea)

Author keywords

Alzheimer's disease; Amyloid protein; Cognitive deficits; Glycyrrhiza uralensis Fisch; Neuroprotective effect; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[25-35]; ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; GLYCYRRHIZA URALENSIS EXTRACT; NEUROTOXIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GLYCYRRHIZA URALENSIS; MAZE TEST; MOUSE; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; CLINICAL RESEARCH; CONFERENCE PAPER; HUMAN; MEDICAL EDUCATION; MEDICAL SCHOOL; ORTHOPEDIC SURGERY; PLANNING; POSTGRADUATE EDUCATION; RESIDENCY EDUCATION; SURGICAL TECHNIQUE;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; COGNITION; COGNITION DISORDERS; GLYCYRRHIZA URALENSIS; MALE; MICE; MICE, INBRED ICR; PEPTIDE FRAGMENTS; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 33747239523     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-006-9023-0     Document Type: Article

References (62)

1. Abei H (1974) Catalase: Methods of enzymatic analysis. Academic Press, Bergmeyer HU, NY
2. Ahlemeyer B, Krieglstein J (2003) Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry 36:S8-S14
3. Akcay YD, Yalcin A, Sozmen EY (2005) The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid-induced injury. Cell Mol Biol Lett 10:321-329
4. Azbill RD, Mu X, Bruce-Keller AJ, Mattson MP, Springer JE (1997) Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765:283-290
5. Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-414
6. Behl C (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 290:471-480
7. Behl C (1999) Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches. Prog Neurobiol 57:301-323
8. Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 16:661-674
9. Benzi G, Pastoris O, Marzatico F, Villa RF (1989) Cerebral enzyme antioxidant system. Influence of aging and phosphatidylcholine. J Cereb Blood Flow Metab 9:373-380
10. Braak H, Braak E (1997) Staging of Alzheimer-related cortical destruction. Int Psychogeriatr 9:257-266
11. Bradley PR (1992) British herbal compendium. British Herbal Medicine Association, Dorset, England
12. Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36:1307-1313
13. Butterfield DA, Kanski J (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Age Dev 122:945-962
14. Carrillo MC, Kanai S, Sato Y, Kitani K (1992) Age-related changes in antioxidant enzyme activities are region and organ, as well as sex, selective in the rat. Mech Age Dev 65:187-198
15. Chang HM, But PPH (1986) Pharmacology and applications of Chinese materia medica. World Scientific, Hong Kong
16. Danh HC, Benedetti MS, Dostert P (1983) Differential changes in superoxide dismutase activity in brain and liver of old rats and mice. J Neurochem 40:1003-1007
17. Daniels WM, van Rensburg SJ, van Zyl JM, Taljaard JJ (1998) Melatonin prevents beta-amyloid-induced lipid peroxidation. J Pineal Res 24:78-82
18. Dhingra D, Parle M, Kulkarni SK (2004) Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 91:361-365
19. Doraiswamy PM (2002) Non-cholinergic strategies for treating and preventing Alzheimer's disease. CNS Drugs 16:811-824
20. Ellman GL, Ho IK (1969) Triton solubilized acetylcholinesterase of brain. J Neurochem 16:1505-1513
21. Flood JF, Morley JE, Roberts E (1991) Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc Natl Acad Sci USA 88:3363-3336
22. Foster S, Chongxi Y (1992) Herbal emissaries: Bringing Chinese herbs to the west. Healing Arts Press, Vermont, pp 112-121
23. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730
24. Hikino H (1985) Recent research on oriental medicinal plants. In: Wagner H, Hikino H, Farnsworth NR (eds) Economic and medicinal plant research. Academic Press, London, pp 53-61
25. Hirohata M, Ono K, Naiki H, Yamada M (2005) Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. Neuropharmacology 49:1088-1099
26. Hsu HY, Chen YP, Shen SJ, Hsu CS, Chen CC, Chang HC (1986) Oriental materia medica: A concise guide. Oriental Healing Arts Institute, Long Beach, Canada, pp 55-57
27. Jang MH, Jung SB, Lee MH, Kim CJ, Oh YT, Kang I, Kim J, Kim EH (2005) Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett 380:26-31
28. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6:153-162
29. Kamei J, Nakamura R, Ichiki H, Kubo M (2003) Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol 469:159-163
30. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Master CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736
31. Kim SC, Byun SH, Yang CH, Kim CY, Kim JW, Kim SG (2004) Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage). Toxicology 197:239-251
32. Laursen SE, Belknap JK (1986) Intracerebroventricular injection in mice. Some methodological refinements. J Pharmacol Methods 16:355-357
33. Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71:952-958
34. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9:133-146
35. Marklund SL, Oreland L, Perdahl E, Winblad B (1983) Superoxide dismutase activity in brains from chronic alcoholics. Drug Alcohol Depend 12:209-215
36. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down's syndrome. Proc Natl Acad Sci USA 82:4245-4249
37. Maurice T, Lockhart BP, Privat A (1996) Amnesia induced by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res 706:181-193
38. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60
39. Nabeshima T, Nitta A (1994) Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med 174:241-249
40. Nishida S, Kikuichi S, Yoshioka S, Tsubaki M, Fujii Y, Matsuda H, Kubo M, Irimajiri K (2003) Induction of apoptosis in HL-60 cells treated with medicinal herbs. Am J Chin Med 31:551-562
41. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
42. Park SE, Kim ND, Yoo YH (2004) Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res 64:2652-2655
43. Pitchumoni SS, Doraiswamy PM (1998) Current status of antioxidant therapy for Alzheimer's disease. J Am Geriatr Soc 46:1566-1572
44. Quintanilla RA, Munoz FJ, Metcalfe MJ, Hitschfeld M, Olivares G, Godoy JA, Inestrosa NC (2005) Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J Biol Chem 280:11615-11625
45. Rao G, Xia E, Richardson A (1990) Effect of age on the expression of antioxidant enzymes in male Fischer F344 rats. Mech Age Dev 53:49-60
46. Rappaport F, Fischl J, Pinto N (1959) An improved method for the estimation of cholinesterase activity in serum. Clin Chim Acta 4:227-230
47. Riederer P, Kondradi C, Shay V, Kienzl E, Birkmayer G, Danielczyk W, Sofic E, Youdim MB (1986) Localization of MAO-A and MAO-B in human brain: A step in understanding the therapeutic action of l-deprenyl. Adv Neurol 45:111-118
48. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT (1998) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50:136-145
49. Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stahelin HB, Hartman R, Gharabawi M (1999) Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial. Br Med J 318:633-640
50. Sawada M, Sester U, Carlson JC (1992) Superoxide radical formation and associated biochemical alterations in the plasma membrane of brain, heart and liver during the lifetime of the rat. J Cell Biochem 48:296-304
51. Schneider LS (1998) New therapeutic approaches to cognitive impairment. J Clin Psychiat 59:8-13
52. Selkoe DJ (1994) Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neurol 53:438-447
53. Sharma D, Maurya AK, Singh R (1993) Age-related decline in multiple unit action potentials of CA3 region of rat hippocampus: Correlation with lipid peroxidation and lipofuscin concentration and the effect of centrophenoxine. Neurobiol Aging 14:319-330
54. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzheimer's disease. Biochem Biophys Acta 26:139-144
55. Strolin Benedetti M, Cini M, Fusi R, Marrari P, Dostert P (1990) The effects of aging on MAO activity and amino acid levels in rat brain. J Neural Transm Suppl 29:259-268
56. Takahashi T, Takasuka N, Iigo M, Baba M, Nishino H, Tsuda H, Okuyama T (2004) Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 95:448-453
57. Tang SY, Whiteman M, Peng ZF, Jenner A, Yong EL, Halliwell B (2004) Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional Chinese medicines. Free Radic Biol Med 36:1575-1587
58. Vanella A, Geremia E, D'Urso G, Tiriolo P, Di Silvestro I, Grimaldi R, Pinturo R (1982) Superoxide dismutase activities in aging rat brain. Gerontology 28:108-113
59. Varadarajan S, Yatin S, Akesenova M, Butterfield DA (2000) Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208
60. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH (2001) Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133:89-96
61. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932
62. Yatin SM, Aksenov M, Butterfield DA (1999) The antioxidant vitamin E modulates amyloid beta- peptide-induced creatine kinase activity inhibition and increased protein oxidation: Implications for the free radical hypothesis of Alzheimer's disease. Neurochem Res 24:427-435